Dong-Yeop Shin

Title: **Innovative Contributions of Dong-Yeop Shin in Pharmaceutical Patents**

Introduction

Dong-Yeop Shin, an accomplished inventor based in Gunpo-si, South Korea, has made significant strides in the field of pharmaceuticals. With a total of two patents to his name, Shin's innovative work primarily focuses on eye drop formulations aiming to treat and prevent macular degeneration.

Latest Patents

Shin's latest patents include an eye drop formulation that comprises a benzopyran derivative. This innovative formulation features (2R,3R,4S)-6-amino-4-[N-(4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)amino]-3-hydroxy-2-methyl-2-dimethoxymethyl-3,4-dihydro-2H-1-benzopyran or its pharmaceutically acceptable salt. Notably, it incorporates propylene glycol as a stabilizing agent and a pH controlling agent, maintaining a pH range of 4.0 to 5.0. This eye drop formulation demonstrates excellent stability and can be stored for extended periods, making it highly effective.

Additionally, Shin's second patent covers a method for purifying the benzopyran derivative, transforming an amorphous form into a novel crystalline structure. This advancement in preparing the crystalline form highlights Shin's dedication to improving the efficacy and stability of pharmaceutical compounds.

Career Highlights

Dong-Yeop Shin currently works at Hanlim Pharmaceutical Co., Ltd., where his contributions continue to influence the pharmaceutical industry. His focused approach to research and innovation in eye treatments has raised the bar for contemporaries and has the potential to impact countless individuals suffering from vision-related issues.

Collaborations

Throughout his career, Shin has collaborated with esteemed colleagues, including Hu-Seong Kim and Geun-Hyeog Lee. These partnerships underscore the importance of teamwork and shared expertise in driving forward innovations in pharmaceutical science.

Conclusion

Dong-Yeop Shin exemplifies the spirit of innovation that characterizes today's leading inventors in the pharmaceutical sector. His groundbreaking patents not only advance the field of eye care but also serve as a testament to the importance of creativity and collaboration in developing effective medical solutions. As Shin continues to push the boundaries of pharmaceutical development, his work remains a beacon of hope for future improvements in treatment and patient care.